Interaction of benzylidene-anabaseine analogues with agonist and allosteric sites on muscle nicotinic acetylcholine receptors. - Wikidata - awgldk - TriplyDB

Interaction of benzylidene-anabaseine analogues with agonist and allosteric sites on muscle nicotinic acetylcholine receptors.

Interaction of benzylidene-anabaseine analogues with agonist and allosteric sites on muscle nicotinic acetylcholine receptors.

http://www.wikidata.org/entity/Q37230903

about

Non-competitive Inhibition of Nicotinic Acetylcholine Receptors by Ladybird Beetle Alkaloids.Insights into nicotinic receptor signaling in nicotine addiction: Implications for prevention and treatment.

P2860

Q39103160-F44D7859-D414-473F-B089-00E68DDCF8F0 Q40111690-70DF8AF8-56A5-409B-AC2C-1C296B41FD68

P2860

Interaction of benzylidene-anabaseine analogues with agonist and allosteric sites on muscle nicotinic acetylcholine receptors.

http://www.wikidata.org/entity/Q37230903

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 26 March 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Interaction of benzylidene-ana ...... tinic acetylcholine receptors.

@en

Interaction of benzylidene-ana ...... tinic acetylcholine receptors.

@nl

type

label

Interaction of benzylidene-ana ...... tinic acetylcholine receptors.

@en

Interaction of benzylidene-ana ...... tinic acetylcholine receptors.

@nl

prefLabel

Interaction of benzylidene-ana ...... tinic acetylcholine receptors.

@en

Interaction of benzylidene-ana ...... tinic acetylcholine receptors.

@nl

P1433

Q37230903-35956EF1-0B79-460F-820B-7EAEB658ADD7

P1476

Q37230903-9FC2C2D8-3A0C-4D22-ABFD-64C5BC46766B

P2093

Q37230903-184416B5-84B1-4561-8109-820394B104C9

Q37230903-7081A052-0DC5-4EEC-9752-BA338AFE32CB

Q37230903-7BE2E6B0-4D5C-4236-8A81-70767A48FA6C

Q37230903-BB221855-9318-4B41-BCA1-606BD4FC8C2C

Q37230903-D370C65C-597B-4803-AF6D-2E6A71764221

Q37230903-DDBDDF09-E395-4A52-8375-7304BF3A703A

P2860

Q37230903-05668311-BE42-4501-94EC-BE244C2EE521

Q37230903-0E0269E4-2080-4B64-BCD2-7088913E9872

Q37230903-12D03958-F331-43CF-BE6C-F2764162D05C

Q37230903-199B6C92-D58D-4B09-9BE7-25E9D86569B3

Q37230903-229F0329-026D-4C4D-BD9B-D2FD8CD33B12

Q37230903-23097361-5123-47A7-BB9D-1AFE54814B5F

Q37230903-24010817-AC3F-499E-8B2A-5450CD92C8D5

Q37230903-24973028-636A-4C2B-B2E0-D2D70FB6177D

Q37230903-2B3F64CE-DFC6-45DA-87BA-4DA9EFBB85B6

Q37230903-312EC026-F5BA-421D-8DF7-A0A8C0F08AA2

P304

Q37230903-99EA41F2-F303-454C-9BC4-119DCD2B175A

P31

Q37230903-28294CB5-1EF3-47A5-86AF-A3984CCB796D

P356

Q37230903-DD913755-0BE3-4F06-A20F-0086208B5FEC

P407

Q37230903-DA833D67-0D13-452F-9CA3-8D5A5112BB77

P433

Q37230903-E618426E-0911-47FC-948E-9E1D01BD3E9F

P478

Q37230903-417F8084-F965-4284-BC5C-C6CBAF1749CE

P577

Q37230903-F7FD70BB-D202-48D3-8882-AAD2B3E1C1A8

P5875

Q37230903-134683DA-D642-4913-B984-E8FFFD15E9DE

P698

Q37230903-3F5292B0-9C92-4075-A96A-B96255F19452

P932

Q37230903-58F9806F-B606-440D-B482-830487A2656F

P356

J.1476-5381.2009.00156.X

P1433

British Journal of Pharmacology

P1476

Interaction of benzylidene-ana ...... tinic acetylcholine receptors.

@en

P2093

F Soti

http://www.w3.org/2001/XMLSchema#string

H R Arias

http://www.w3.org/2001/XMLSchema#string

H Xing

http://www.w3.org/2001/XMLSchema#string

K Macdougall

http://www.w3.org/2001/XMLSchema#string

M P Blanton

http://www.w3.org/2001/XMLSchema#string

W R Kem

http://www.w3.org/2001/XMLSchema#string

P2860

Proof-of-concept trial of an alpha7 nicotinic agonist in schizophrenia

Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction

Relative toxicities and neuromuscular nicotinic receptor agonistic potencies of anabasine enantiomers and anabaseine

Metabolism and disposition of GTS-21, a novel drug for Alzheimer's disease

Safety, pharmacokinetics, and effects on cognitive function of multiple doses of GTS-21 in healthy, male volunteers.

3-[2,4-Dimethoxybenzylidene]anabaseine (DMXB) selectively activates rat alpha7 receptors and improves memory-related behaviors in a mecamylamine-sensitive manner.

Anabaseine is a potent agonist on muscle and neuronal alpha-bungarotoxin-sensitive nicotinic receptors.

Analysis of 3-(4-hydroxy, 2-Methoxybenzylidene)anabaseine selectivity and activity at human and rat alpha-7 nicotinic receptors.

Initial phase 2 trial of a nicotinic agonist in schizophrenia.

Unique general anesthetic binding sites within distinct conformational states of the nicotinic acetylcholine receptor.

P304

320-330

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1476-5381.2009.00156.X

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

157

http://www.w3.org/2001/XMLSchema#string

P577

2009-03-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

24250284

http://www.w3.org/2001/XMLSchema#string

P698

19338581

http://www.w3.org/2001/XMLSchema#string

P932

2697798

http://www.w3.org/2001/XMLSchema#string